Disclosures for "Serum Neurofilament Light Chain Levels in Parkinson’s Disease Therapy: Preliminary Results from a Phase 2 Clinical Trial of Allogenic Bone Marrow-derived Mesenchymal Stem Cell"
-
Dr. Martinez Lemus has nothing to disclose.
-
Dr. Tharp has nothing to disclose.
-
Prof. Ellmore has nothing to disclose.
-
Mr. Ritter has nothing to disclose.
-
Dr. Le has nothing to disclose.
-
Dr. Onuigbo has nothing to disclose.
-
Dr. Schiess has nothing to disclose.